Korecyte is a growing international biotech company developing next generation CAR-T immunotherapy products for clinical translation and development. We are proud to have partnerships that enable us to make our life-changing therapies available to cancer patients.

Korecyte Bio is an international biotech startup based between the Netherlands and United Kingdom that was established in 2023. Our mission is to develop next-generation CAR-T cellular immunotherapies

Interested in Korecyte Bio? Contact us or read more about our scientific approach.